RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents

Titre

BSO - Titre

RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents

DOI

DOI10.1016/j.neuropharm.2017.03.012

DOAI

DOAI10.1016/j.neuropharm.2017.03.012

Identifiant WoS

WOS:000401678600018

Accès ouvert

OA - Oui

Source - Accès ouvert

OA - Non

Type d'accès

Poids de l’Open access dans la production CNRS